201 0

Full metadata record

DC FieldValueLanguage
dc.contributor.author이현-
dc.date.accessioned2018-11-13T01:14:32Z-
dc.date.available2018-11-13T01:14:32Z-
dc.date.issued2016-09-
dc.identifier.citationCANCER RESEARCH, v. 76, NO. 22, Page. 6568-6576en_US
dc.identifier.issn0008-5472-
dc.identifier.issn1538-7445-
dc.identifier.urihttp://cancerres.aacrjournals.org/content/76/22/6568-
dc.identifier.urihttps://repository.hanyang.ac.kr/handle/20.500.11754/80342-
dc.description.abstractTumor heterogeneity influences the clinical outcome of patients with cancer, and the diagnostic method to measure the tumor heterogeneity needs to be developed. We analyzed genomic features on pairs of primary and multiple metastatic lymph nodes from six patients with lung cancer using whole-exome sequencing and RNA sequencing. Although somatic single-nucleotide variants were shared in primary lung cancer and metastases, tumor evolution predicted by the pattern of genomic alterations was matched to anatomic location of the tumors. Four of six cases exhibited a branched clonal evolution pattern. Lymph nodes with acquired somatic variants demonstrated resistance to the cancer treatment. In this study, we demonstrated that multiple biopsies and sequencing strategies for different tumor regions are required for a comprehensive understanding of the landscape of genetic alteration and for guiding targeted therapy in advanced primary lung cancer. (C) 2016 AACR.en_US
dc.description.sponsorshipThis work was supported by the Samsung Medical Center and Health Technology R&D Project, the Ministry of Health & Welfare (HI13C2096 to W.Y. Park).en_US
dc.language.isoenen_US
dc.publisherAMER ASSOC CANCER RESEARCHen_US
dc.subjectEML4-ALK FUSION GENEen_US
dc.subjectINTRATUMOR HETEROGENEITYen_US
dc.subjectSIGNALING PATHWAYen_US
dc.subjectKINASE INHIBITORen_US
dc.subjectSEQUENCING DATAen_US
dc.subjectEGFRen_US
dc.subjectMUTATIONSen_US
dc.subjectCHEMOTHERAPYen_US
dc.subjectRESISTANCEen_US
dc.subjectVARIANTSen_US
dc.titleMolecular Evolution Patterns in Metastatic Lymph Nodes Reflect the Differential Treatment Response of Advanced Primary Lung Canceren_US
dc.typeArticleen_US
dc.relation.no22-
dc.relation.volume76-
dc.identifier.doi10.1158/0008-5472.CAN-16-0873-
dc.relation.page6568-6576-
dc.relation.journalCANCER RESEARCH-
dc.contributor.googleauthorUm, Sang-Won-
dc.contributor.googleauthorJoung, Je-Gun-
dc.contributor.googleauthorLee, Hyun-
dc.contributor.googleauthorKim, Hojoong-
dc.contributor.googleauthorKim, Kyu-Tae-
dc.contributor.googleauthorPark, Jinha-
dc.contributor.googleauthorHayes, D. Neil-
dc.contributor.googleauthorPark, Woong-Yang-
dc.relation.code2016002300-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.pidnamuhanayeyo-
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE